Pediatric non-Helicobacter pylori atrophic gastritis: a case series

Jennifer Pogoriler1, Daniel Kamin, Jeffrey D Goldsmith

  • 1*Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA †Department of Gastroenterology and Nutrition ‡Department of Pathology, Beth Israel Deaconess Medical Center, Children's Hospital Boston, and Harvard Medical School, Boston, MA.

Insights

Autoimmune atrophic gastritis is rare in children but may be underdiagnosed. Early diagnosis requires high suspicion, especially in those with autoimmune conditions or iron deficiency, to prevent complications.

Area of Science:

  • Pediatric Gastroenterology
  • Autoimmune Diseases
  • Pathology

Background:

  • Autoimmune atrophic gastritis (AAG) is typically seen in older adults.
  • Recent literature suggests AAG occurs in younger adults, especially those with other autoimmune conditions and iron-deficiency anemia.
  • Pediatric AAG is rare, underdiagnosed, and often reported in single cases.

Purpose of the Study:

  • To investigate the clinical presentation, pathological findings, and natural history of pediatric AAG.
  • To expand knowledge on AAG in children not associated with Helicobacter pylori infection.

Main Methods:

  • Retrospective analysis of 12 pediatric patients diagnosed with atrophic gastritis.
  • Review of clinical history, endoscopic findings, and histopathology.
  • Follow-up data analysis for disease progression and complications.

Main Results:

  • The study identified 12 pediatric patients (8 months–18 years) with AAG.
  • Seven patients had co-existing autoimmune diseases or immunodeficiency.
  • Common findings included oxyntic atrophy, intramucosal inflammation, metaplasia, and ECL cell hyperplasia; one patient developed adenocarcinoma.

Conclusions:

  • Pediatric AAG is an underdiagnosed entity often missed due to non-specific endoscopic findings.
  • High index of suspicion is crucial for diagnosis, particularly in children with autoimmune diseases or iron-deficiency anemia.
  • Accurate diagnosis by pathologists is essential for timely management and monitoring of potential complications.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.4K
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
2
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
37
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
872
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.8K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.2K